Focal Therapy

Urologic oncologist Dr. Jim Hu provides an overview of focal therapy for prostate cancer — who it may be right for, and what patients should know before pursuing it. Highlights of this video include:

• Focal therapy is still considered experimental: there isn’t enough long-term data yet to know how well it works
• Patients may be good candidates are usually those with a single area of lower-grade (Grade Group 2) cancer that shows up clearly on MRI
• Four out of 10 men who have focal therapy are found to have cancer elsewhere in the prostate within two years
• A patient’s personal priorities — especially protecting sexual function — play an important role in this decision

Speakers:

Jim C. Hu, MD, MPH, Professor of Urology, Weill Cornell Medicine
Phillip Koo, MD, Chief Medical Officer, Prostate Cancer Foundation

Transcript Coming Soon